"Is Pfizer Winning Its $43 Billion Bet?"

"Pfizer's oncology portfolio holds more than 25 approved medicines - and nine of these are blockbusters or have blockbuster potential.Pfizer aims to launch eight or more oncology blockbusters by 2030"

The Seagen purchase came with four approved treatments. Three are ADCs: Padcev for advanced bladder cancer, Adcetris for Hodgkin lymphoma, and Tivdak for cervical cancer. Seagen also brought Tukysa, for a certain form of breast cancer. Including these four, Pfizer's oncology portfolio holds more than 25 approved medicines -- and nine of these are blockb…